rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-12-17
|
pubmed:abstractText |
Despite the demonstrated benefits of low-density lipoprotein cholesterol (LDL-C) reduction in reducing the risk of coronary heart disease, many patients receiving lipid-lowering therapy fail to achieve LDL-C goals. We compared the effects of rosuvastatin and atorvastatin in reducing LDL-C and achieving LDL-C goals in patients with primary hypercholesterolemia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1097-6744
|
pubmed:author |
pubmed-author:IstadHelgeH,
pubmed-author:LoveJ KJK,
pubmed-author:LuurilaOlaviO,
pubmed-author:OlssonAnders GAG,
pubmed-author:PearsJohnJ,
pubmed-author:Rosuvastatin Investigators Group,
pubmed-author:SouthworthHarryH,
pubmed-author:StenderSteenS,
pubmed-author:TuomilehtoJaakkoJ,
pubmed-author:WiklundOlovO,
pubmed-author:WilpshaarJ WJW
|
pubmed:issnType |
Electronic
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1044-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12486429-Adult,
pubmed-meshheading:12486429-Aged,
pubmed-meshheading:12486429-Anticholesteremic Agents,
pubmed-meshheading:12486429-Cholesterol, LDL,
pubmed-meshheading:12486429-Double-Blind Method,
pubmed-meshheading:12486429-Female,
pubmed-meshheading:12486429-Fluorobenzenes,
pubmed-meshheading:12486429-Heptanoic Acids,
pubmed-meshheading:12486429-Humans,
pubmed-meshheading:12486429-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:12486429-Hypercholesterolemia,
pubmed-meshheading:12486429-Male,
pubmed-meshheading:12486429-Middle Aged,
pubmed-meshheading:12486429-Pyrimidines,
pubmed-meshheading:12486429-Pyrroles,
pubmed-meshheading:12486429-Sulfonamides
|
pubmed:year |
2002
|
pubmed:articleTitle |
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.
|
pubmed:affiliation |
Department of Medicine and Care, University Hospital, Linköping, Sweden. andol@kfc.liu.se
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|